Table of contents
February 2007 Volume 3 No 2
Top of page
Editorial
Top of page
Viewpoint
Top of page
Research Highlights
Novel treatment shows promise for type 1 primary hyperoxaluria
62Antiretroviral therapy retards progression of HIV-associated nephropathy
62Study provides strong support for association between cancer and membranous nephropathy
63Fosinopril could reduce cardiovascular events in end-stage renal disease
63Comparing management models for tunneled-cuffed-catheter-related bacteremia
64Low-dose gentamicin effectively prevents catheter-related bacteremia
64Failure to meet targets compromises outcomes of long-term hemodialysis
65Oral hygiene of pediatric renal transplant recipients is improved by sonic toothbrushing
65Cefotaxime lock improves survival of tunneled cuffed hemodialysis catheters in diabetics
65Redox-active iron level predicts viability of renal grafts from non-heart beating donors
66Comparing neuropsychological functioning before and after kidney transplantation
66Top of page
Practice Points
Renal hemodynamic responses to renin–angiotensin blockade differ in men and women
68Primary aldosteronism: renal effects compared with primary hypertension
70Sleep apnea in peritoneal dialysis: nocturnal versus continuous ambulatory treatment
72Low levels of triiodothyronine as an independent risk factor for death in hemodialysis patients
74Pediatric en bloc kidney transplants: excellent long-term function compared with adult living donor kidneys
76Favorable outcomes of kidneys from non-heart-beating donors whose cardiac arrest occurred out of hospital
78Top of page
Reviews
Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists
82doi:10.1038/ncpneph0401 | Full Text | PDF (380K)
Therapy Insight: orthopedic complications after solid organ transplantation in childhood
96doi:10.1038/ncpneph0384 | Full Text | PDF (348K)
Top of page
Case Studies
Acute lymphoblastic leukemia presenting as acute renal failure
106doi:10.1038/ncpneph0400 | Full Text | PDF (331K)

A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis
111doi:10.1038/ncpneph0373 | Full Text | PDF (410K)


